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CARDIAC AND PULMONARY 
REPLACEMENT 
AGE-RELATED 
DEVELOPMENT OF HUMAN 
ANTI-PIG XENOANTIBODY 
Human cytotoxic natural xenoantibodies are believed to be of the immuno- 
globulin M class in nature. However, a thorough understanding of the 
development of these natural antixenodonor xenoantibodies remains incom- 
plete. In this study, serum samples were obtained from newborn, infant, and 
adult human beings. An enzyme-linked immunosorbent assay was used to 
determine the binding of human natural immunoglobulin M xenoantibodies to 
pig aortic endothelial cells and pig lymphocytes. A complement-mediated 
cTtotoxicity assay was used to measure the cytotoxicity of newborn, infant, and 
adult serum to cultured pig aortic endothelial cells and pig lymphocytes. Adult 
human serum contained both natural immunoglobulin M and immunoglobu- 
lin G xenoantibodies to pig endothelial cells and lymphocytes, whereas 
newborn infant serum contained only immunoglobnlin G xenoantibodies. Only 
adult human serum was cytotoxic to pig endothelial cells and lymphocytes. 
Human immunoglobulin M xenoantibodies became detectable by age 1 month. 
By age 2 months these natural anti-pig xenoantibodies reached serum levels 
equivalent to those in the human adult and resulted in similar cytotoxicity to 
that of adult human serum. These findings indicate that (1) natural anti-pig 
immunoglobulin M xenoantibodies are absent from newborn infant human 
serum, (2) newborn human serum is not cytotoxic to pig endothelial cells and 
lymphocytes despite the presence of immunoglobulin G xenoantibodies that 
bind to pig endothelial cells and lymphocytes, and (3) natural anti-pig 
immunoglobulin M xenoantibodies begin to develop as early as age 1 month 
and by age 2 months attain a circulating level comparable tothat found in the 
adult. (J THORAC CARDIOVASC SURG 1995;110:1023-9) 
He Xu, MD, Nillo Edwards, MD, Jonathan M. Chen, MD, Xu Dong, RN, 
and Robert E. Michler, MD, New York, N.Y. 
T he critical shortage of donor hearts for cardiac allotransplantation had led to a search for alter- 
native sources of suitable organs, a' 2 The need for 
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grafts is particularly desperate among newborn in- 
fants with congenital malformations, for whom the 
long wait for an available organ not infrequently 
results in death. Closely related species such as 
nonhuman primates are a possible source of donor 
organs on the basis of their humanlike anatomy and 
physiologic makeup and their genetic proximity to 
man. However, as donors these animals rarely fall in 
the universal donor blood type group O and they 
harbor zoonoses infectious to man. 
An alternate donor pool would be animals that 
are available in all human sizes, do not express ABO 
antigens or express all blood types commonly, and 
harbor few agents infectious to man. As a result of 
these logistic considerations, the pig has been pro- 
posed as an alternative to the nonhuman primate 
donor. The pig is available in all human sizes and pig 
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Fig. 1. Binding of adult human atural IgM and IgG xenoantibodies to cultured pig aortic endothelial cells 
was measured by ELISA. 
cardiac anatomy and physiologic makeup are strikingly 
similar to those of human beings. 3Pigs can be raised to 
have minimal risk of epizootic disease transmission 
and pig endothelial cells express ABH antigens weak- 
ly. 4 More than 90 million pigs are slaughtered annually 
as a food source, which makes these animals a more 
ethically acceptable alternative donor organ source. 5
Organs transplanted between distantly related spe- 
cies such as the pig and the baboon are rejected in a 
rapid and violent manner termed hyperacute rejection. 
This rejection reaction is believed to be initiated by the 
binding of naturally occurring xenoantibodies to donor 
organ endothelium leading to activation of the com- 
plement cascade. 6'7 Natural xenoantibodies have been 
shown to be present in all mammalian species. 8 The 
activation of complement by the binding of natural 
antibody causes endothelial cell dysfunction character- 
ized by cell swelling, interstitial hemorrhage, inflam- 
mation, fibrin and platelet hrombus formation, and 
graft death in minutes to hours. 6' 7 Limited prolonga- 
tion of distantly related xenograft survival has been 
achieved by depletion of these natural antibodies with 
plasma exchange, 9 plasmapheresis, 1° donor-organ ad- 
sorption, ll, 12 and inhibition of complement with cobra 
venom factor 13 or soluble complement receptor type 1.14 
Investigations regarding human and primate natural 
xenoantibodies have suggested that they are of the 
immunoglobulin M (IgM) class of immunoglobu- 
lin.6, 7,15,16 We have previously identified these natural 
xenoantibodies to be present only at low levels in the 
serum of newborn baboons. 17 To further our under- 
standing of the development of natural human xeno- 
antibodies, we examined serum samples obtained from 
newborn, infant, and adult human beings to evaluate 
the existence and cytotoxicity of human natural anti- 
pig xenoantibodies. 
Material and methods 
Preparation of serum. Pooled human serum samples 
were obtained from the following age groups: newborn 
(term newborn infant cord blood, n = 10), 1 month (n = 
5), 2 months (n = 5), 4 months (n = 5), 8 months (n = 5), 
1 year (n = 5), 2 years (n = 5), 5 years (n = 5), 10 years 
(n = 5), and adult (>18 years, n = 10). All serum samples 
were heat-treated for 30 minutes at 56°C to inactivate 
complement and were subsequently stored at -80 ° C. 
Target cells. Pig aortic endothelial cells were isolated 
with the use of collagenase and primary culture of these 
cells was done in Dulbecco's modified Eagle medium 
(DMEM) (Gibco, Grand Island, N.Y.) supplied with 10% 
fetal calf serum (Gibco) according to the method de- 
scribed by Rosiers, Nees, and GerlachJ 8 These endothe- 
lial cells were detached by trypsin and transferred into 
new tissue culture flasks. Subculture of pig aortic endo- 
thelial cells was done in DMEM containing 10% fetal calf 
serum. These endothelial cells were used for immunoas- 
say before the tenth generation of cell division. 
Once they obtained confluence, the cultured endothe- 
lial cells were transferred to fiat-bottomed 96-well plates 
and allowed to grow until the formation of endothelial cell 
monolayers. Both pig lymphocytes and cultured pig aortic 
endothelial cells were used as target cells. 
Pig lymphocytes were isolated from peripheral blood 
by flotation on a FicoU-hypaque gradient (Gallard 
Schleseaga Co., New York, N.Y.). The cells were washed 
twice with phosphate-buffered saline solution (PBS) (Sig- 
ma Chemical Co., St Louis, Mo.). The viability of pig 
lymphocytes was measured by trypan blue exclusion and 
standardized to exceed 95%. 
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Fig. 2. ELISA demonstrates age-related binding of human natural IgM xenoantibodies to cultured pig 
endothelial cells. Unlike adult human serum, newborn human serum contains low levels of natural anti-pig 
IgM xenoantibodies. 
Immunoassay for natural xenoantibodies. An enzyme- 
linked immunosorbent assay (ELISA) was used to detect he 
binding of natural anti-pig xenoantibodies to cultured pig 
vascular endothelial cells according to the method escribed 
by Platt and colleagues. 19In brief, cultured pig aortic endo- 
thelial cell monolayers were fixed with cold 0,01% glutaral- 
dehyde for 5 minutes at 4 ° C and then washed three time 
with cold PBS. After the final wash, the plates were incu- 
bated with 1% bovine serum albumin in PBS at 4 ° C for 1 
hour to block the nonspecific binding of antibodies and then 
were exposed to a variety of diluted serum samples (primary 
antibodies) for 60 minutes at 4 ° C. Cells were washed three 
times with PBS and incubated with secondary antibodies 
(goat anti-human IgM conjugated to alkaline phosphatase 
and goat anti-human IgG conjugated to alkaline phos- 
phatase) for another 60 minutes. After the final washing with 
PBS, developer solution was added to each well and color 
development progressed in the dark. Finally, absorbance at 
405 nm was measured by an ELISA reader. One percent 
bovine serum albumin was used as the negative control, and 
pooled adult human sera were used as positive controls. The 
methods for ELISA analysis of fresh pig lymphocytes were 
identical to those previously described herein for cultured 
pig aortic endothelial cells. 
A complement-mediated cytotoxicity assay was done to 
measure the cytotoxicity of newborn and adult human 
serum to porcine lymphocytes. A total of 10 × 10 6 porcine 
lymphocytes were labeled with 100 tzCi of chromium 51 
(Amersham Corp., Arlington Heights, Ill.) at 37 ° C for 60 
minutes and then washed three times with Hanks solution 
(Gibco) to remove free chromium 51. A total of 1 × 106 
pig lymphocytes were added to a 96-well round-bottom 
microtiter plate with 50/xl newborn or adult human serum 
samples and 50 /xl of diluted rabbit complement (1:1 
dilution), and the plate was incubated for 60 minutes at 
37 ° C. After the final incubation, the plate underwent 
centrifugation at 1500 rounds per minute for 10 minutes 
and 100/xl of supernatant was collected with the radioac- 
tivity of released chromium 51 from the pig lymphocytes 
determined by gamma counter analysis. 
Cultured pig endothelial cells were transferred into 24- 
well tissue culture plates and grown to confluence. The 
endothelial cell monolayers were labeled with 4 tzCi per well 
of chromium 51 at 37 ° C for 2 hours and then washed three 
times with DMEM to remove free chromium 51. After the 
final wash, endothelial cell monolayers were incubated 
with 100 ixl serum and 100 Ixl rabbit complement (1:1 
dilution) at 37°C for 4 hours. Supernatants (100 ~1) 
were collected, and the c romium 51 released from the 
pig endothelial cells was determined with use of a 
gamma counter. Pig serum was used as a negative 
control and cell lysis buffer as a positive control (Fisher 
Scientific, Orangeburg, N.Y.). 
Percent cytotoxicity was calculated as follows: 
Percent of cytotoxicity 
100 x measured cpm - negative control cpm 
positive control cpm - negative control cpm 
where cpm is the counts per minute of chromium 51 
determined in the assay. 
Results 
Endothelial cells. Adu l t  human IgM and IgG 
natural  anti-pig endothel ia l  cell xenoant ibodies 
were demonstrated to b ind to cultured pig aort ic 
endothel ia l  cells and at equivalent levels (Fig. 1). 
The age-re lated binding of human natural  IgM 
xenoant ibodies to cultured pig endothel ia l  cells 
demonstrated barely detectable levels at birth, 
which increased only slightly by age 1 month  (Fig. 
1026 Xu et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
October 1995 
O 
2.0 
1.8 
1.6 
1.4 
1.2 
1.0 
0.8 
0.6 
0.4 
0.2 
0.0 
Background=0.(~2 
! ! ! ! ! ! ! I ! ! 
0 1 2 4 6 8 12 24 60 Adult 
Age (monthl 
Fig. 3. ELISA demonstrates age-related binding of human natural IgG antibodies to cultured pig aortic 
endothelial cells. 
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Fig. 4. Age-related evelopment of cytotoxicity of human serum to cultured pig endothelial cells was 
determined by complement-mediated cytotoxicity assay. Newborn human serum demonstrated no cyto- 
toxicity to pig endothelial cells. 
2). By age 2 months IgM xenoantibody binding was 
at a level comparable to that measured in pooled 
adult human sera (Fig. 2). In contrast, he binding of 
natural IgG xenoantibodies to pig aortic endothelial 
cells was readily detectable at birth and by age 1 
month had achieved levels comparable to those of 
the adult (Fig. 3). 
Pooled adult human serum was markedly cyto- 
toxic to cultured pig aortic endothelial cells. In 
contrast, newborn human serum was not cytotoxic to 
pig aortic endothelial cells, which suggests that IgM 
is the cytotoxic xenoantibody. However, cytotoxicity 
of infant serum to pig endothelial cells occurred by 
age 2 months (Fig. 4). 
Lymphocytes. The age-related binding of human 
natural IgM xenoantibodies to pig lymphocytes 
demonstrated barely detectable levels at birth, 
which increased only slightly by age 1 month (Fig. 
5). By age 2 months IgM xenoantibody binding 
was at a level comparable with that measured in 
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Fig. 5. Age-related binding of natural IgM xenoantibodies to pig lymphocytes was measured by ELISA. 
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Fig. 6. Complement-mediated cytotoxicity assay demonstrates high level of cytotoxicity of adult human 
serum to pig tymphocytes. 
pooled adult human sera (Fig. 5). Insufficient 
serum was available to perform IgG binding studies 
(ELISA). 
Significant cytotoxicity by adult human serum to 
pig lymphocytes was demonstrated, whereas no cy- 
totoxicity was demonstrated by newborn human 
serum to pig lymphocytes (Fig, 6). 
Discussion 
Hyperacute rejection of discordant xenografts i
believed to be caused by the binding of natural 
xenoantibodies to donor organ endothelial cells, a 
process that ultimately results in the activation of 
the complement cascade and subsequent graft 
loss.6, 7, 11 Investigations that characterized the na- 
ture and function of natural xenoantibodies have 
been reported previously by our transplantation 
research laboratory and by other investiga- 
tors.6, 7, 15, 16 In light of our previous finding that 
human cytotoxic natural xenoantibodies are IgM in 
nature and are either absent or barely detectable in 
newborn baboon serum, 17 we undertook the present 
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investigation to better understand the process by 
which natural IgM xenoantibodies develop in hu- 
man beings. 
It has been documented that the selective placen- 
tal transfer of maternal immunoglobulin from 
mother to fetus can provide immediate passive 
protection from bacterial infection. By this mecha- 
nism, IgG is transferred uring gestation, whereas 
IgM, IgA, and IgD are not because of their large 
molecular weight (molecular weight 900,000 for 
IgM). 19-21 Our data demonstrate hat newborn hu- 
man serum contains barely detectable levels of 
natural anti-pig IgM xenoantibodies and intermedi- 
ate levels of IgG xenoantibodies. Newborn human 
serum is not cytotoxic to pig lymphocytes orcultured 
pig endothelial cells despite the binding of natural 
IgG xenoantibody. Human cytotoxic natural anti-pig 
IgM xenoantibodies begin to develop at age 1 month 
and ultimately attain levels comparable to those of 
the adult by age 2 months. 
IgM antibody synthesis has been described as 
early as the eleventh week of gestation i  the spleen 
and the colon. 22' 23 Stiehm and Fudenberg 2°have 
suggested that human IgM antibodies develop rap- 
idly after birth and have demonstrated IgM antibody 
levels in human infants between 1and 3 months old 
to be 30% -+ 11% of adult levels, those between 4
and 6 months to be 43% + 17% of adult levels, and 
those between 7 and 12 months to be 55% _+ 23% of 
adult levels, with levels increasing slowly after the 
first year of life. However, at present, it is unclear 
whether natural xenoantibodies exhibit develop- 
mental patterns imilar to those of these previously 
investigated IgM antibodies. Preliminary results in- 
dicate that the production of these natural xenoan- 
tibodies after birth may be induced by both living 
and killed bacteria. 24 
We have previously demonstrated barely detect- 
able levels of natural anti-pig IgM xenoantibody in 
newborn baboon serum 17 and prolongation of car- 
diac xenograft survival in a newborn pig-to-baboon 
model. 25 Kemp and associates 26 demonstrated de- 
layed hyperacute r jection in a newborn rabbit-to- 
pig kidney discordant xenotransplantation model in 
which natural xenoantibodies were absent from 
newborn recipients. 
In summary, human cytotoxic natural anti-pig 
IgM xenoantibodies are barely detectable at birth. 
These xenoantibodies (as measured by ELISA) be- 
gin to develop at approximately age 1 month. These 
cytotoxic IgM xenoantibodies develop rapidly be- 
tween age 1 and 2 months and ultimately attain 
levels comparable to those of the adult by age 2 
months. Human natural IgG xenoantibodies are 
found in all human sera, although newborn sera 
express lower levels of binding to pig aortic endo- 
thelial cells than do adult sera. The nature and 
function of these IgG xenoantibodies, however, re- 
main poorly characterized. These results offer prom- 
ising evidence for the potential success of clinical 
newborn cardiac xenotransplantation; however, fur- 
ther investigations are indicated regarding the 
mechanism of natural xenoantibody development 
and the long-term results of experimental neonatal 
xenotransplantation. 
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